Company / Profit Margin
RHYTHM PHARMACEUTICALS, INC. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-103.6%
FY2025
5-year range
-238.5% / -103.6%
FY2023-FY2025
Trend
+48.3%
vs FY2024
Sector context
#97 of 146
Health Care
What the data says
At -103.6%, RHYTHM PHARMACEUTICALS, INC.'s profit margin ranks #97 of 146 in the Health Care sector. Improved from -238.5% to -103.6% over the past 2 years.
Based on SEC 10-K filings.
-103.6% in FY2025.
Improved from -238.5% to -103.6% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#97 of 146 in Health CareTop 66% of 146This company -103.6% Sector average -796.3%
▼
+87.0% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 48.3% year-over-year.
- Currently 692.7pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -103.6% | +48.3% |
| FY2024 | -200.3% | +16.0% |
| FY2023 | -238.5% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026